1-6 of 6
Alexander Cohen
Close
Sort by
Journal Articles

Outcomes Following Placement of Venous Stents for Treatment of Thrombotic Venous Disease

Karen Breen, MD, Prakash Saha, Narayan Karanunithy, Beverley Hunt, Alexander Cohen, Vickie McDonald, James Uprichard, Michael Fay, MBBCHBAO, FRCPath, Stephen Black
Journal: Blood
Blood (2017) 130 (Supplement 1): 697.
https://doi.org/10.1182/blood.V130.Suppl_1.697.697
Published: 2017
Journal Articles

Major Bleeding and Bleeding Events Requiring Hospitalization in the First Three Months Following Vitamin K Antagonists Therapy in Patients with First Venous Thromboembolism

Carlos Martinez, MD MSc, Alexander Cohen, MD, Anja Katholing, MSc, Christopher Wallenhorst, MSc, Xiaoyan Li, PhD, Gail Wygant, RN
Journal: Blood
Blood (2017) 130 (Supplement 1): 2076.
https://doi.org/10.1182/blood.V130.Suppl_1.2076.2076
Published: 2017
Journal Articles

Impact of D-Dimer Assays Performed at Local Labs Vs. Central Laboratory in the Evaluation of Apex Trial Outcomes

Lisa K. Jennings, PhD, Jayaprakash Kotha, PhD MBBS, Mason Dixon, BS, Alexander Cohen, MD, John T Curnutte, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2391.
https://doi.org/10.1182/blood.V130.Suppl_1.2391.2391
Published: 2017
Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD
Journal: Blood
Blood (2014) 124 (21): 1543.
https://doi.org/10.1182/blood.V124.21.1543.1543
Published: 2014
Journal Articles

Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism

Giancarlo Agnelli, MD, Harry Roger Buller, MD, PhD, Alexander Cohen, MD, Madelyn Curto, DVM, Alexander S. Gallus, M.D., Margot R. Johnson, MD, BSC, Anthony R. Porcari, PhD, PharmD, Gary E Raskob, PhD, Jeffrey I. Weitz, MD
Journal: Blood
Blood (2012) 120 (21): LBA-1.
https://doi.org/10.1182/blood.V120.21.LBA-1.LBA-1
Published: 2012
Journal Articles

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Clinical Trials & Observations
Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers
Journal: Blood
Blood (2008) 112 (6): 2242–2247.
https://doi.org/10.1182/blood-2008-05-160143
Published: 2008
Includes: Supplemental data